IMMUNE DESIGN CORP.
DelistedCIK 1437786fmd_0XAPQ8BNHD8REFGH2SGRVPMEVSManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Dec 31, 2018, 25 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|
| Total revenues | 3 | 2 | 6 | 10 | 13 | 7 | 2 |
| Cost of revenue | 2 | 1 | 1 | 1 | 0 | 0 | 1 |
| Gross profit | 1 | 1 | 6 | 9 | 13 | 7 | 1 |
| Research and development | 9 | 12 | 23 | 33 | 45 | 44 | 42 |
| Total operating expenses | 14 | 17 | 36 | 49 | 67 | 60 | 59 |
| Operating income | (11) | (15) | (30) | (39) | (54) | (53) | (57) |
| Other non-operating income (expense) | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
| Net income | (11) | (16) | (34) | (39) | (54) | (52) | (55) |
| Net income to common shareholders | (11) | (16) | (34) | (39) | (54) | (52) | (55) |